ReviewVirulence2023
Pathogenicity and virulence of
Review in Virulence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Review
- Genomic epidemiology and antimicrobial resistance profile ofMicrobial genomics · 2026Article
- Third-generation cephalosporin-induced L-form transition inMicrobiology spectrum · 2026Article
- Genome-based re-evaluation of the ECA75F sequence and development of a dual-probe real-time PCR assay for differentiatingMicrobiology spectrum · 2026Article
- Genome-wide analysis exploring mechanisms used bymSystems · 2026Article
- Bacteriophage Therapy AgainstAntibiotics (Basel, Switzerland) · 2026Review
- Investigation of the azithromycin resistance rate and related genes involved in this resistance in clinical Shigella species collected from children with diarrhea in Ahvaz, Southwest Iran.Molecular biology reports · 2026Article
- Shifts in the Lung Microbiota and Antibiotic Resistance Genes Occur With Aging in Patients With Lower Respiratory Tract Infections.BioMed research international · 2026Article
- TheeLife · 2025Article
- Enhanced virulence and stress tolerance are signatures of epidemiologically successful Shigella sonnei.Nature communications · 2025Article
- Shigellosis.Lancet (London, England) · 2025Review
- ThebioRxiv : the preprint server for biology · 2025Article
- A cell-cell communication signal fromApplied and environmental microbiology · 2025Article
- Molecular epidemiology of a multidrug-resistantMicrobial genomics · 2025Article
- Comprehensive analysis of antimicrobial resistance dynamics among broiler and duck intensive production systems.Scientific reports · 2025Article
- Cellulase activity and age-based variation of intestinal microbiota in Hezuo pigs.Frontiers in microbiology · 2025Article
- Antibiotic-ResistantCase reports in infectious diseases · 2025Article
- High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against MultipleInternational journal of molecular sciences · 2024Article
- Twenty-five years of sentinel laboratory-based surveillance of shigellosis in a high-income country endemic for the disease, Israel, 1998 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.